> Investors > 

News Releases

Date Title  
Toggle Summary Alan Levin Elected Chairman of the Board of Directors
Albert Eilender to Remain as Chairman Emeritus until Retiring at 2018 Annual Meeting PORT WASHINGTON, N.Y. , June 01, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products,
Printer Friendly Version
Toggle Summary ACETO Reports Fiscal 2018 Third Quarter Results
  Obtains a Waiver for Financial Covenants Generates Operating Cash Flows of $9.5 Million for the Third Quarter and $56.4 Million for the Nine-Months Ended March 31 , 2018  Board of Directors Declares a Dividend of $0.01 per Share PORT WASHINGTON, N.Y.
Printer Friendly Version
Toggle Summary ACETO Corporation Schedules Third Quarter Fiscal 2018 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , April 19, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
Toggle Summary ACETO Board Takes Proactive Steps to Address Business and Financial Challenges
Negotiation of Waiver with Lenders; Reduction of Dividend Announced Nonreliance on Prior Full-Year Earnings Guidance Appoints Rebecca Roof as Interim CFO Names Alan Levin Non-Executive Vice Chairman Initiates Evaluation of Strategic Alternatives PORT WASHINGTON, N.Y.
Printer Friendly Version
Toggle Summary ACETO to Appeal U.S. Government Ruling Regarding Certain Lucid Pharma Contracts
PORT WASHINGTON, N.Y. , Feb. 27, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, has been notified by the U.S.
Printer Friendly Version
Toggle Summary ACETO Appoints Edward J. Borkowski Chief Financial Officer
PORT WASHINGTON, N.Y. , Feb. 16, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed Edward J. 
Printer Friendly Version
Toggle Summary ACETO Subsidiary, Rising Pharmaceuticals, Launches Atenolol Tablets, 25mg, 50mg and 100mg
PORT WASHINGTON, N.Y. , Feb. 07, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising
Printer Friendly Version
Toggle Summary ACETO Reports Fiscal 2018 Second Quarter Results Printer Friendly Version
Toggle Summary ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y. , Feb. 01, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that its Board of
Printer Friendly Version
Toggle Summary ACETO Corporation Schedules Second Quarter Fiscal 2018 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , Jan. 18, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
top